Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Why This Promising Drug Will Be Pfizer's Next Blockbuster
Why This Promising Drug Will Be Pfizer's Next Blockbuster
Why This Promising Drug Will Be Pfizer's Next Blockbuster
Submitted by
admin
on July 10, 2022 - 11:53pm
Source:
Motley Fool
News Tags:
Pfizer
etrasimod
ulcerative colitis
Headline:
Why This Promising Drug Will Be Pfizer's Next Blockbuster
snippet:
The medication could soon be approved to treat an addressable market of nearly 200,000 patients.
Etrasimod, intended to treat ulcerative colitis, could haul in $1 billion in annual sales for Pfizer.
The market is overly pessimistic about the eventual drop in Pfizer's coronavirus-related revenue
Do Not Allow Advertisers to Use My Personal information